Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study.
Potestio L, Patruno C, Del Gaudio M, Ortoncelli M, Ribero S, Barei F, Ferrucci SM, Bonzano L, Trave I, Guanti MB, Gurioli C, Piraccini BM, Gori N, Ippoliti E, Peris K, Grigolato L, Rossi M, Foti C, Romita P, Tirone B, Nettis E, Esposito M, Fargnoli MC, Magnanimi LM, Pezzolo E, Hansel K, Stingeni L, Satta R, Mariano M, Pigliacelli F, Margiotta FM, Romanelli M, Ingurgio RC, Costanzo A, Narcisi A, Corazza M, Antiga E, Morrone P, Rubegni P, Calabrese L, Lazzeri L, Rubegni G, Guarneri F, Zerbinati N, Carugno A, Puca RV, Sarno O, Marasca C, Martina E, di Vico F, Napolitano M.
Potestio L, et al. Among authors: satta r.
Int J Dermatol. 2025 Aug 20. doi: 10.1111/ijd.70027. Online ahead of print.
Int J Dermatol. 2025.
PMID: 40836376